Online citations, reference lists, and bibliographies.
← Back to Search

BRD4 PROTAC As A Novel Therapeutic Approach For The Treatment Of Vemurafenib Resistant Melanoma: Preformulation Studies, Formulation Development And In Vitro Evaluation

Drishti Rathod, Yige Fu, Ketan Patel

Cite This
Download PDF
Analyze on Scholarcy
Share